BPC-157 by Meditech is a pharmaceutical-grade synthetic pentadecapeptide formulation containing 5 mg of Body Protection Compound-157 per vial, supplied as 3 vials of lyophilized peptide alongside 3 vials of 2 mL sterile reconstitution water. BPC-157 is a 15-amino acid synthetic peptide derived from a protective protein sequence isolated from human gastric juice, with an extensive and growing research history in regenerative medicine, gastroenterology, and neuropeptide pharmacology literature documenting its broad tissue repair and cytoprotective properties across multiple organ systems.
 
✔ Key Research Insights
Studied for its role in accelerating tendon, ligament, and muscle fiber repair in research subjects, with documented effects on fibroblast proliferation, collagen synthesis, and growth factor upregulation — including VEGF and FGF — at musculoskeletal injury sites in preclinical and peptide research literature
Investigated for its gastroprotective and gastrointestinal mucosal repair properties, with documented effects on gut lining integrity, ulcer healing, and intestinal barrier function representing one of the most extensively researched pharmacological areas of BPC-157 across comparative peptide literature
Researched for its pro-angiogenic activity, with documented stimulation of new blood vessel formation at tissue injury sites via VEGF pathway upregulation, supporting improved nutrient and oxygen delivery to damaged tissue in research observations
Examined for its anti-inflammatory properties at cellular injury sites, with documented modulation of inflammatory cytokine activity and oxidative stress reduction across preclinical peptide research protocols
Documented for its neuroprotective and nerve regeneration properties, with effects on dopaminergic and serotonergic neurotransmitter system modulation and peripheral nerve repair investigated across neurological peptide research literature
Researched for its influence on post-surgical and post-injury recovery parameters in documented research protocols, with consistent regenerative activity noted across multiple tissue types in comparative BPC-157 research
Manufactured by Meditech to pharmaceutical-grade lyophilized peptide purity and formulation standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: BPC-157
Molecule: Body Protection Compound-157 (Synthetic Pentadecapeptide)
Concentration: 5 mg per vial
Volume: 3 vials × 5 mg lyophilized peptide + 3 vials × 2 mL sterile water
Form: Lyophilized peptide powder requiring reconstitution prior to administration
Administration: Subcutaneous injection; localized or systemic depending on research protocol
Storage: Lyophilized — store at −20°C; Reconstituted — refrigerate at 2–8°C and use within documented stability window
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
BPC-157 is a synthetic 15-amino acid pentadecapeptide derived from the amino acid sequence 4–13 of the body protection compound protein found in human gastric juice. In research subjects, BPC-157 exerts its regenerative effects through multiple interconnected molecular pathways, distinguishing it from single-mechanism peptide compounds in comparative research literature. At the vascular level, BPC-157 has been documented to upregulate vascular endothelial growth factor (VEGF) expression and stimulate nitric oxide synthesis, promoting angiogenesis — the formation of new blood vessels — at sites of tissue damage, thereby restoring nutrient and oxygen supply to hypoxic injured tissue. At the cellular level, BPC-157 has been investigated for its stimulatory effects on fibroblast proliferation and migration, with downstream influences on collagen deposition and extracellular matrix remodeling documented across musculoskeletal repair research. In the gastrointestinal tract — the biological origin context of the parent compound — BPC-157 has been extensively researched for its cytoprotective effects on gastric and intestinal mucosal epithelia, with documented healing activity across multiple gastrointestinal pathology models including ulceration, inflammatory bowel conditions, and intestinal barrier disruption in preclinical research literature. Neurologically, BPC-157 has been investigated for its modulation of dopaminergic and serotonergic neurotransmitter systems and its documented effects on peripheral nerve regeneration, representing a pharmacologically distinct research area of growing interest in neuropeptide literature. Reconstitution with bacteriostatic water is standard protocol prior to subcutaneous administration in documented research settings, with lyophilized storage at −20°C ensuring peptide stability and bioactivity prior to use.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade lyophilized peptide purity and formulation standards
Synthetic pentadecapeptide with a broad multi-mechanism regenerative research profile spanning musculoskeletal repair, gastrointestinal protection, angiogenesis, anti-inflammatory activity, and neuroprotection across comparative peptide pharmacology literature
One of the most extensively researched synthetic peptides in regenerative medicine literature, with documented activity across multiple tissue types and organ systems
Supplied with sterile reconstitution water and requiring storage at −20°C in lyophilized form, consistent with standard pharmaceutical peptide preservation protocols
Widely referenced in regenerative medicine, gastroenterology, and neuropeptide pharmacology research under the BPC-157 and Body Protection Compound designations